Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Anika Therapeutics, Inc.

Anika Therapeutics, Inc. (ANIK) Stock Overview

Explore Anika Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ANIK●NASDAQ
HealthcareMedical - Devices
$15.25
$0.57(3.60%)
U.S. Market opens in 6h 19m

Anika Therapeutics, Inc. (ANIK)

Meyka AI Score

Z

Key Financials

Market Cap202.9M
P/E Ratio-19.33
EPS (TTM)$0.49
ROE-0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$12.38
3 Months$17.29
1 Year Target$7.41

ANIK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Anika Therapeutics, Inc. (ANIK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.05, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $7.41.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -19.33 and a market capitalization of 202.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.60%
5-Day Change
-5.40%
1-Month Change
7.17%
3-Month Change
-4.69%
6-Month Change
63.80%
Year-to-Date (YTD) Change
58.69%
1-Year Change
35.68%
3-Year Change
-39.00%
5-Year Change
-62.01%
All-Time (Max) Change
335.71%

Contact Information

https://www.anika.com
781 457 9000
32 Wiggins Avenue, Bedford, MA, 01730

Company Facts

2,350 Employees
IPO DateMay 3, 1993
CountryUS
Actively Trading

Frequently Asked Questions